KEMPF DAVID A 4
4 · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · Filed Jun 19, 2009
Insider Transaction Report
Form 4
KEMPF DAVID A
DirectorCOO/CFO
Transactions
- Purchase
Series A Convertible Preferred Stock
2009-06-17$1.00/sh+7,500$7,500→ 316,667 totalExercise: $0.75From: 2009-06-17→ common stock (10,000 underlying) - Purchase
warrants
2009-06-17+3,750→ 320,417 totalExercise: $1.50From: 2009-06-17Exp: 2010-12-17→ common stock (3,750 underlying)
Holdings
- 2,800(indirect: By IRA)
Common Stock
- 300,000
options
Exercise: $1.00From: 2012-02-11Exp: 2019-02-11→ common stock (100,000 underlying) - 100,000
Options
Exercise: $1.00From: 2010-02-11Exp: 2019-02-11→ Common Stock (100,000 underlying) - 200,000
Options
Exercise: $1.00From: 2011-02-11Exp: 2019-02-11→ common stock (100,000 underlying) - 3,000(indirect: By IRA)
Common Stock
- 306,667
Series A Convertible Preferred Stock
Exercise: $0.75From: 2009-04-15→ common stock (6,667 underlying)
Footnotes (1)
- [F1]not applicable